Adipose redistribution in human immunodeficiency virus-seropositive patients: Association with CD4 response

被引：10
|
作者：
Wurtz, R
Ceaser, S
机构：
[1] Evanston NW Healthcare, Evanston, IL USA
[2] Northwestern Univ, Evanston, IL USA
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 06期
关键词：
D O I：
10.1086/317483
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We have noted that human immunodeficiency virus (HIV)-seropositive patients who develop adipose redistribution (AR) while receiving combination antiretroviral therapy (ART) also tend to have a better response to ART, as indicated by the relative change in CD4 percent compared to those who don't develop AR on therapy. Whether the possible benefits of the improved CD4 response outweigh the metabolic and cosmetic problems associated with lipodystrophy is not known.
引用
收藏
页码：1497 / 1498
页数：2
相关论文
共 50 条
  • [1] Progression of CD4 count among human immunodeficiency virus-seropositive patients in a tertiary care hospital of Tripura, North East India
    Majumdar, Tapan
    Das, Niladri Sekhar
    Modak, Ayan
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2020, 41 (02) : 213 - +
  • [2] PROBLEMS OF CLASSIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PEDIATRIC-PATIENTS
    ROGERS, MF
    CURRAN, JW
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (12) : 888 - 889
  • [3] Perianal ulcers in a human immunodeficiency virus-seropositive man
    Corti, Marcelo
    De Carolis, Luis
    Messina, Fernando
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (01) : 146 - 146
  • [4] COLPOSCOPIC EVALUATION OF HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN
    MAIMAN, M
    TARRICONE, N
    VIEIRA, J
    SUAREZ, J
    SERUR, E
    BOYCE, JG
    OBSTETRICS AND GYNECOLOGY, 1991, 78 (01): : 84 - 88
  • [5] HUMAN PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN
    SUN, XW
    ELLERBROCK, TV
    LUNGU, O
    CHIASSON, MA
    BUSH, TJ
    WRIGHT, TC
    OBSTETRICS AND GYNECOLOGY, 1995, 85 (05): : 680 - 686
  • [6] Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patients
    Noormohamed, FH
    Youle, MS
    Higgs, CJ
    Martin-Munley, S
    Gazzard, BG
    Lant, AF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 293 - 297
  • [7] Comparison of intestinal function in human immunodeficiency virus-seropositive patients in Kampala and London
    Murphy, B
    Taylor, C
    Crane, R
    Okong, P
    Bjarnason, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (05) : 491 - 495
  • [8] QUANTITATIVE WESTERN IMMUNOBLOTTING ANALYSIS IN SURVEY OF HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS
    SCHIAVINI, DG
    PUEL, JML
    AVEROUS, SA
    BAZEX, JA
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (09) : 2062 - 2066
  • [9] POLYMORPHIC LIGHT ERUPTION IN A HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE MAN
    LEGUYADEC, T
    PICARD, C
    CRICKX, B
    SERRAFTIRCAZES, D
    GOETTMANN, S
    CALLOT, C
    BELAICH, S
    EUROPEAN JOURNAL OF DERMATOLOGY, 1994, 4 (08) : 621 - 622
  • [10] Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women
    Uvin, SC
    Caliendo, AM
    OBSTETRICS AND GYNECOLOGY, 1997, 90 (05): : 739 - 743
12345